A Phase IIb clinical trial of ADX-102 in dry eye disease.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Reproxalap (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 09 Nov 2017 According to an Aldeyra Therapeutics media release, results from this trial are expected to be announced in the second half of 2018.
- 13 Sep 2017 New trial record
- 12 Sep 2017 According to an Aldeyra Therapeutics media release, company is planning to initiate this study in the first half of 2018.